subscribeSubscribe
Pfizer`s tafamidis will hold its own against new meds: analysts

Pfizer`s tafamidis will hold its own against new meds: analysts
Angus Liu FIERCE PHARMA
18 Sep 2023
Share Share
Pfizer, Scripps Sue to Block Copy of ‘Most Expensive’ Heart Drug

Pfizer, Scripps Sue to Block Copy of ‘Most Expensive’ Heart Drug
BLOOMBERG LAW
12 Aug 2023
Share Share
FDA Confirms Paragraph IV Patent Litigation for Tafamidis Capsules

FDA Confirms Paragraph IV Patent Litigation for Tafamidis Capsules
FDA
30 Jun 2023
Share Share
Pfizer prevails in proposed class action lawsuit over copays

Pfizer prevails in proposed class action lawsuit over copays
Kevin Dunleavy FIERCE PHARMA
06 Apr 2023
Share Share
Pfizer’s VYNDAQEL/VYNDAMAX Reduces Risk of All-Cause Mortality by 41% in ATTR-CM

Pfizer’s VYNDAQEL/VYNDAMAX Reduces Risk of All-Cause Mortality by 41% in ATTR-CM
BUSINESSWIRE
20 Dec 2021
Share Share
NICE says ‘no’ to Pfizer’s Vyndaqel for rare heart condition

NICE says ‘no’ to Pfizer’s Vyndaqel for rare heart condition
Richard Staines PHARMAPHORUM
13 May 2021
Share Share
Pfizer Vyndaqel copay lawsuit could bring drug pricing shockwave

Pfizer Vyndaqel copay lawsuit could bring drug pricing shockwave
E.Sagonowsky FIERCE PHARMA
13 Oct 2020
Share Share
Tafamidis After Therapy Delay Provides Long-Term Benefit for Patients

Tafamidis After Therapy Delay Provides Long-Term Benefit for Patients
Ed Susman FIRSTWORLDPHARMA
09 Oct 2020
Share Share
Regulator OKs Pfizer’s cardiomyopathy drug Vyndamax

Regulator OKs Pfizer’s cardiomyopathy drug Vyndamax
S. Hyun-tai KOREABIOMEDICALREVIEW
23 Aug 2020
Share Share
Vyndaqel, Ibrance boost Pfizer as it eyes COVID-19 shot launch

Vyndaqel, Ibrance boost Pfizer as it eyes COVID-19 shot launch
Angus Liu FIERCE PHARMA
29 Jul 2020
Share Share